These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1544283)

  • 1. The erythromycin breath test selectively measures P450IIIA in patients with severe liver disease.
    Lown K; Kolars J; Turgeon K; Merion R; Wrighton SA; Watkins PB
    Clin Pharmacol Ther; 1992 Mar; 51(3):229-38. PubMed ID: 1544283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of urinary 6-beta-cortisol and the erythromycin breath test as measures of hepatic P450IIIA (CYP3A) activity.
    Watkins PB; Turgeon DK; Saenger P; Lown KS; Kolars JC; Hamilton T; Fishman K; Guzelian PS; Voorhees JJ
    Clin Pharmacol Ther; 1992 Sep; 52(3):265-73. PubMed ID: 1526083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early postoperative erythromycin breath test correlates with hepatic cytochrome P4503A activity in liver transplant recipients.
    Schmidt LE; Olsen AK; Stentoft K; Rasmussen A; Kirkegaard P; Dalhoff K
    Clin Pharmacol Ther; 2001 Nov; 70(5):446-54. PubMed ID: 11719731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythromycin breath test predicts oral clearance of cyclosporine in kidney transplant recipients.
    Turgeon DK; Normolle DP; Leichtman AB; Annesley TM; Smith DE; Watkins PB
    Clin Pharmacol Ther; 1992 Nov; 52(5):471-8. PubMed ID: 1424421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of human lung cytochromes P450 that are immunochemically related to cytochrome P450IIE1 and cytochrome P450IIIA.
    Wheeler CW; Wrighton SA; Guenthner TM
    Biochem Pharmacol; 1992 Jul; 44(1):183-7. PubMed ID: 1632834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importance of cytochrome P-450IIIA activity in determining dosage and blood levels of FK 506 and cyclosporine in liver transplant recipients.
    Cakaloglu Y; Tredger JM; Devlin J; Williams R
    Hepatology; 1994 Aug; 20(2):309-16. PubMed ID: 7519161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of the erythromycin breath test for in vivo assessments of cytochrome P4503A activity and dosage individualization.
    Chiou WL; Jeong HY; Wu TC; Ma C
    Clin Pharmacol Ther; 2001 Oct; 70(4):305-10. PubMed ID: 11673745
    [No Abstract]   [Full Text] [Related]  

  • 8. Concurrent administration of the erythromycin breath test (EBT) and oral midazolam as in vivo probes for CYP3A activity.
    McCrea J; Prueksaritanont T; Gertz BJ; Carides A; Gillen L; Antonello S; Brucker MJ; Miller-Stein C; Osborne B; Waldman S
    J Clin Pharmacol; 1999 Dec; 39(12):1212-20. PubMed ID: 10586386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic cytochrome P-4503A (CYP3A) activity in the elderly.
    Hunt CM; Westerkam WR; Stave GM; Wilson JA
    Mech Ageing Dev; 1992 Jun; 64(1-2):189-99. PubMed ID: 1630156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythromycin breath test and clinical transplantation.
    Watkins PB
    Ther Drug Monit; 1996 Aug; 18(4):368-71. PubMed ID: 8857552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mdr1 limits CYP3A metabolism in vivo.
    Lan LB; Dalton JT; Schuetz EG
    Mol Pharmacol; 2000 Oct; 58(4):863-9. PubMed ID: 10999959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythromycin breath test as an assay of glucocorticoid-inducible liver cytochromes P-450. Studies in rats and patients.
    Watkins PB; Murray SA; Winkelman LG; Heuman DM; Wrighton SA; Guzelian PS
    J Clin Invest; 1989 Feb; 83(2):688-97. PubMed ID: 2913056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporine metabolism by P450IIIA in rat enterocytes--another determinant of oral bioavailability?
    Kolars JC; Stetson PL; Rush BD; Ruwart MJ; Schmiedlin-Ren P; Duell EA; Voorhees JJ; Watkins PB
    Transplantation; 1992 Mar; 53(3):596-602. PubMed ID: 1549853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between postoperative erythromycin breath test and early morbidity in liver transplant recipients.
    Schmidt LE; Rasmussen A; Kirkegaard P; Dalhoff K
    Transplantation; 2003 Jul; 76(2):358-63. PubMed ID: 12883193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the dapsone recovery ratio and the erythromycin breath test as in vivo probes of CYP3A activity in patients with rheumatoid arthritis receiving cyclosporine.
    Stein CM; Kinirons MT; Pincus T; Wilkinson GR; Wood AJ
    Clin Pharmacol Ther; 1996 Jan; 59(1):47-51. PubMed ID: 8549033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of correlations among three putative in vivo probes of human cytochrome P4503A activity in young healthy men.
    Kinirons MT; O'Shea D; Downing TE; Fitzwilliam AT; Joellenbeck L; Groopman JD; Wilkinson GR; Wood AJ
    Clin Pharmacol Ther; 1993 Dec; 54(6):621-9. PubMed ID: 8275617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythromycin breath test.
    Watkins PB
    Clin Pharmacol Ther; 2000 May; 67(5):577-8. PubMed ID: 10824637
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of ketoconazole on the erythromycin breath test and the dapsone recovery ratio.
    Kinirons MT; Krivoruk Y; Wilkinson GR; Wood AJ
    Br J Clin Pharmacol; 1999 Feb; 47(2):223-5. PubMed ID: 10190659
    [No Abstract]   [Full Text] [Related]  

  • 19. The erythromycin breath test as a predictor of cyclosporine blood levels.
    Watkins PB; Hamilton TA; Annesley TM; Ellis CN; Kolars JC; Voorhees JJ
    Clin Pharmacol Ther; 1990 Aug; 48(2):120-9. PubMed ID: 2116259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythromycin as a specific substrate for cytochrome P4503A isozymes and identification of a high-affinity erythromycin N-demethylase in adult female rats.
    Zhang XJ; Thomas PE
    Drug Metab Dispos; 1996 Jan; 24(1):23-7. PubMed ID: 8825186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.